![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 20
Zeitschriftenartikel
Metzgeroth, G.; Schwaab, J.; Naumann, N.; Haferlach, C.; Jawhar, M.; Horny, H.-P.; Dirk, J.; Kratz-Albers, K.; Krämer, D.; Mayer, S.; Storch, N.; Burchert, A.; Haferlach, T.; Cross, N. C. P.; Hofmann, W.-K.; Fabarius, A. und Reiter, A.
(2017):
Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia.
In: Oncology Research and Treatment, Bd. 40: S. 196
Bellos, F.; Sotlar, K.; Jeromin, S.; Haferlach, C.; Haferlach, T. und Kern, W.
(2016):
Assessment of CD30 expression on mast cells in systemic mastocytosis by immunohistochemistry versus multiparameter flow cytometry and correlation to clinical parameters.
In: Oncology Research and Treatment, Bd. 39: S. 152
Jawhar, M.; Schwaab, J.; Meggendorfer, M.; Naumann, N.; Kluger, S.; Horny, H.-P.; Sotlar, K.; Haferlach, T.; Fabarius, A.; Hofmann, W.-K.; Reiter, A. und Metzgeroth, G.
(2016):
Mast cell leukemia: clinical heterogeneity, molecular aberrations and prognostic factors.
In: Oncology Research and Treatment, Bd. 39: S. 24
Büchner, T.; Krug, U. O.; Gale, R. Peter; Heinecke, A.; Sauerland, M. C.; Haferlach, C.; Schnittger, S.; Haferlach, T.; Müller-Tidow, C.; Stelljes, M.; Mesters, R. M.; Serve, H. L.; Braess, J.; Spiekermann, K.; Staib, P.; Grüneisen, A.; Reichle, A.; Balleisen, L.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Lengfelder, E.; Görlich, D.; Faldum, A.; Köpcke, W.; Hehlmann, R.; Wörmann, B. J.; Berdel, W. E. und Hiddemann, W.
(2016):
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.
In: Leukemia, Bd. 30, Nr. 8: S. 1781-1784
Krug, U.; Berdel, W. E.; Gale, R. P.; Haferlach, C.; Schnittger, S.; Müller-Tidow, C.; Braess, J.; Spiekermann, K.; Staib, P.; Beelen, D.; Serve, H.; Schliemann, C.; Stelljes, M.; Balleisen, L.; Maschmeyer, G.; Grüneisen, A.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Hehlmann, R.; Lengfelder, E.; Thiel, E.; Reichle, A.; Aul, C.; Ludwig, W.-D.; Kern, W.; Haferlach, T.; Köpcke, W.; Görlich, D.; Sauerland, M. C.; Heinecke, A.; Wörmann, B. J.; Hiddemann, W. und Büchner, T.
(2016):
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
In: Leukemia, Bd. 30, Nr. 6: S. 1230-1236
Jawhar, M.; Schwaab, J.; Schnittger, S.; Meggendorfer, M.; Pfirrmann, Markus; Sotlar, K.; Horny, H. P.; Metzgeroth, G.; Kluger, S.; Naumann, N.; Haferlach, C.; Haferlach, T.; Valent, P.; Hofmann, W. K.; Fabarius, A.; Cross, N. C. und Reiter, A.
(2016):
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.
In: Leukemia, Bd. 30, Nr. 1: S. 136-143
Schwaab, J.; Schnittger, S.; Sotlar, K.; Walz, C.; Fabarius, A.; Pfirrmann, Markus; Kohlmann, A.; Grossmann, V.; Meggendorfer, M.; Horny, H. P.; Valent, P.; Jawhar, M.; Teichmann, M.; Metzgeroth, G.; Erben, P.; Ernst, T.; Hochhaus, A.; Haferlach, T.; Hofmann, W. K.; Cross, N. C. und Reiter, A.
(2013):
Comprehensive mutational profiling in advanced systemic mastocytosis.
In: Blood, Bd. 122, Nr. 14: S. 2460-2466
Hehlmann, R.; Grimwade, D.; Simonsson, B.; Apperley, J.; Baccarani, M.; Barbui, T.; Barosi, G.; Bassan, R.; Béné, M. C.; Berger, Ursula; Büchner, T.; Burnett, A.; Cross, N. C.; de Witte, T. J.; Dohner, H.; Dombret, H.; Einsele, H.; Engelich, G.; Foa, R.; Fonatsch, C.; Gökbuget, Nicola; Gluckman, E.; Gratwohl, A.; Guilhot, F.; Haferlach, C.; Haferlach, T.; Hallek, M.; Hasford, Joerg; Hochhaus, A.; Hoelzer, D.; Kiladjian, J. J.; Labar, B.; Ljungman, P.; Mansmann, Ulrich; Niederwieser, D. W.; Ossenkoppele, G.; Ribera, J. M.; Rieder, H.; Serve, H.; Schrotz-King, P.; Sanz, M. A. und Saußele, Susanne
(2011):
The European LeukemiaNet: achievements and perspectives.
In: Haematologica, Bd. 96, Nr. 1: S. 156-162
Saußele, Susanne; Adam, K.; Hochhaus, A.; Béné, M. C.; Büchner, T.; Burnett, A.; Finazzi, G.; Fonatsch, C.; Gluckman, E.; Gökbuget, Nicola; Grimwade, D. J.; Haferlach, T.; Hallek, M.; Hasford, Joerg; Hoelzer, D.; Ljungman, P.; Niederwieser, D. W.; Serve, H.; Simonsson, B.; de Witte, T. J. und Hehlmann, R.
(2006):
Klinische Forschung im „European LeukemiaNet”.
In: Deutsche Medizinische Wochenschrift - DMW, Bd. 131, Nr. 43: S. 2423-2426
Kohlmann, A.; Schoch, C.; Dugas, Martin; Rauhut, S.; Weninger, F.; Schnittger, S.; Kern, W. und Haferlach, T.
(2005):
Pattern robustness of diagnostic gene expression signatures in leukemia.
In: Genes, Chromosomes and Cancer, Bd. 42, Nr. 3: S. 299-307
Kohlmann, A.; Schoch, C.; Dugas, Martin; Schnittger, S.; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2005):
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
In: Leukemia, Bd. 19, Nr. 6: S. 953-964
Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C.
(2005):
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.
In: Genes, Chromosomes and Cancer, Bd. 43, Nr. 2: S. 113-127
Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C.
(2005):
Global approach to the diagnosis of leukemia using gene expression profiling.
In: Blood, Bd. 106, Nr. 4: S. 1189-1198
Schoch, C.; Kohlmann, A.; Dugas, Martin; Kern, W.; Hiddemann, Wolfgang; Schnittger, S. und Haferlach, T.
(2005):
Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
In: Leukemia, Bd. 19, Nr. 7: S. 1224-1228
Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2004):
Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.
In: Leukemia, Bd. 18, Nr. 1: S. 63-71
Lenz, G.; Dreyling, Martin; Schiegnitz, E.; Haferlach, T.; Hasford, Joerg; Unterhalt, Michael und Hiddemann, Wolfgang
(2004):
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
In: Journal of Clinical Oncology, Bd. 22, Nr. 24: S. 4926-4933
Dugas, Martin; Messerer, D.; Hasford, Joerg; Haferlach, T.; Heinze, B.; Ludwig, W.; Rieder, H.; Schoch, R.; Schwartz, S. und Thiel, E.
(2003):
German Multicenter Study Group for Adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results.
In: Annals of Hematology, Bd. 82, Nr. 2: S. 83-87
Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2003):
Molecular characterization of acute leukemias by use of microarray technology.
In: Genes, Chromosomes and Cancer, Bd. 37, Nr. 4: S. 396-405
Dugas, Martin; Merk, S.; Breit, S.; Schoch, C.; Haferlach, T. und Kääb, S.
(2003):
Bioinformatics for medical diagnostics: assessment of microarray data in the context of clinical databases.
In: AMIA Annual Symposium Proceedings: S. 210-214
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, Martin; Hiddemann, Wolfgang und Haferlach, T.
(2003):
Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.
In: Haematologica, Bd. 88, Nr. 3: S. 351-352